Blood marker for protein misfolding outperforms P-tau 217 as early predictor of Alzheimer's disease

A survey led by Professor Klaus Gerwert (PRODI, Ruhr University Bochum, Germany) has determined that the misfolding of the amyloid beta macromolecule is the strongest blood-based predictor of Alzheimer's illness successful the asymptomatic stage, indicating the hazard of the illness years earlier it is clinically diagnosed and overmuch earlier than the wide utilized plasma biomarker P-tau 217.